TrialHaematologica2015

Health-related quality of life from the MM-003 trial of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed and/or refractory multiple myeloma.

Kevin W Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.